Thymosin alpha-1 restored T-cell function, NK cell activity, and cytokine production in mice immunosuppressed by cyclophosphamide, supporting its use as an immune recovery agent during cancer chemotherapy.
Multi-cell restorationThymosin alpha-1 restored T-cells, NK cells, AND cytokine production — broad immune rebuilding from a single peptide
What the researchers found
Thymosin alpha-1 restored T-cell proliferation, NK cell cytotoxicity, and Th1 cytokine production (IL-2, IFN-γ) in cyclophosphamide-immunosuppressed mice, demonstrating broad immune reconstitution capacity.
Why it matters
Chemotherapy-induced immune suppression increases infection risk and reduces anti-cancer immunity. An agent that quickly restores immune function could reduce complications and improve cancer treatment outcomes.
How the study worked
Animal study in cyclophosphamide-immunosuppressed mice. Thymosin alpha-1 administered SC. T-cell proliferation, NK cell activity, and cytokine production measured and compared to immunosuppressed and normal controls.
What this study cannot tell us
Mouse model with complete immune suppression. Human immune recovery may be slower or different. The optimal timing and dosing for clinical use was not established.
How to read the evidence
Preliminary animal evidence with comprehensive immune function measurements in a clinically relevant immunosuppression model.
When this study was published
Published in 2001. Thymosin alpha-1 is used clinically in some countries as an immune adjuvant during chemotherapy.
The bigger picture
Cancer treatment often requires destroying the immune system to kill cancer. Thymosin alpha-1's ability to rapidly rebuild immunity could shorten the dangerous immunocompromised window and enable more aggressive treatment protocols.
Questions still open
- Should thymosin alpha-1 be given routinely after chemotherapy cycles?
- Does immune restoration improve anti-cancer immunity as well as infection resistance?
- What is the optimal timing for thymosin alpha-1 relative to chemotherapy?
Common questions
Can thymosin alpha-1 help after chemotherapy?
Is it used in cancer patients?
Read the original research
Restoration of immunocyte functions by thymosin alpha1 in cyclophosphamide-induced immunodeficient mice.
Immunopharmacology and immunotoxicology, 23(1), 75-82
Citation
Ohmori, H; Kamo, M; Yamakoshi, K; Nitta, M H; Hikida, M; Kanayama, N. (2001). Restoration of immunocyte functions by thymosin alpha1 in cyclophosphamide-induced immunodeficient mice.. Immunopharmacology and immunotoxicology, 23(1), 75-82.